Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 174   

Articles published

GSK 1,464.12 -0.38 (-0.03%)
price chart
Deutsche Bank Reaffirms "Hold" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �hold� rating restated by research analysts at Deutsche Bank in a report released on Monday.
GlaxoSmithKline plc (GSK) - Investment Analysts' Weekly Ratings Changes
Shares of GlaxoSmithKline plc (LON:GSK) opened at 1471.50 on Monday. GlaxoSmithKline plc has a 52 week low of GBX 1200.668 and a 52 week high of GBX 1706.00.
GlaxoSmithKline plc Stock Rating Reaffirmed by Deutsche Bank (GSK)
A number of other firms have also recently commented on GSK. Analysts at Liberum Capital reiterated a sell rating on shares of GlaxoSmithKline plc in a research note on Friday. Separately, analysts at Credit Suisse reiterated an underperform rating on ...
GSK - GlaxoSmithKline plc: Regulatory update on transaction with Novartis
GlaxoSmithKline plc (LSE/NYSE: GSK) is today providing this update to its announcement of 22 April 2014 relating to the major three-part transaction with Novartis AG (the "Original Announcement").
Glaxo's Deal With Novartis Is Approved By US Regulator FTC  London South East
Related articles »  
Morning Stock Stories: CBS Corporation (CBS), GlaxoSmithKline plc (GSK ...
GlaxoSmithKline plc (NYSE:GSK) of the Healthcare sector (Drug Manufacturers - Major) has gained 0.06% per share early this morning.
Keys To Investing In A Bull Market [GlaxoSmithKline plc (ADR), Facebook Inc]
bearbull2 Chad Shoop: U.S. stocks are still very much in a bull market - just one with increasing volatility. In October, stocks suffered the sharpest drop since 2011, and then rebounded just as rapidly to close the month at, or near, all-time highs ...
Related articles »  
Deutsche Bank Reiterates "Hold" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (ADR) logo Deutsche Bank reaffirmed their hold rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report released on Wednesday.
Related articles »  
JPMorgan Chase & Co. Reiterates Neutral Rating for GlaxoSmithKline plc (GSK)
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily ...
JPMorgan Chase & Co. Reiterates "Neutral" Rating for ...  WKRB News
Halma plc Rating Reiterated by Credit Suisse (HLMA)  Mideast Time
Related articles »  
GlaxoSmithKline plc Coverage Initiated by Analysts at BNP Paribas (GSK)
GlaxoSmithKline plc logo Analysts at BNP Paribas started coverage on shares of GlaxoSmithKline plc (NYSE:GSK) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.
GlaxoSmithKline plc Receives Consensus Rating of "Hold" from Analysts (NYSE ...
GlaxoSmithKline plc (NYSE:GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related ...
Related articles »